Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation
The de-extinction startup is looking to double or triple its previous valuation, according to the report.
-
-
Dimension Capital’s $800M third fund shows the intersection of science and compute is booming
The four-year-old firm’s latest fund is 60% larger than its second vehicle announced 18 months ago.
-
Science Corporation’s vision-restoring chip wins EU approval
“The thing that the space needs is a company making $100 million a year of revenue,” Science Corp. CEO Max Hodak said.
-
CareCloud begins to notify hundreds of thousands after hackers stole medical records
The health tech data giant, which handles vast amounts of patients’ medical data, said hackers struck one of its protected health data stores.
